Their data demonstrated that elevated mRNA levels for prostasin inhibitor, PN-1, coincides with the acquisition of malignant properties, whereas the mRNA level of prostasin is relatively stable during colorectal cancer carcinogenesis [62]. The gene discussed is PRSS8; the disease is colorectal cancer.